Daiichi Sankyo Submits Application for Additional Indication of Mirogabalin in Japan
an additional indication related to central neuropathic pain (CNP) in Japan.
Read morean additional indication related to central neuropathic pain (CNP) in Japan.
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.